Somatostatin (CAS 51110-01-1)

Alternate Names:

AGCKNFFWKTFTSC; Growth hormone release inhibiting factor; GHIH; Somatostatin-14; Somatotropin release inhibiting factor; SRIF; 38916-34-6

Application:

Somatostatin is a peptide hormone that regulates the endocrine system

CAS Number: 51110-01-1

Purity: ≥97%

Molecular Weight: 1637.88

Molecular Formula: C76H104N18O19S2

Somatostatin is a 14-amino acid peptide that functions as an inhibitory hormone and affects neurotransmission and cell proliferation through interaction with G proteint-coupled somatostatin receptors. It is expressed in the central and peripheral nervous systems and parts of the digestive system. In the anterior pituitary gland, somatostatin inhibits the release of growth hormone and thyroid-stimulating hormones. Somatostatin suppresses the release of the gastrointestinal hormones gastrin, cholecystokinin, secretin, motilin, vasoactive intestinal peptide, gastric inhibitory polypeptide and enteroglucagon, and of the pancreatic hormones insulin and glucagon. Somatostatin is homologous to cortistatin. Somatostatin is an inhibitor of Calcium Channel Protein.

Mifamurtide

Synonyms: Mifamurtide, L-Alaninamide

Product Code TRC-M343940-25MG

CAS Number 83461-56-7

Product Format Neat

Molecular Formula C59 H109 N6 O19 P

Molecular Weight 1237.499

Muramyl dipeptide (MDP) analogue; immunomodulator and antineoplastic.Mifamurtide(CGP19835; MTP-PE) is a drug against osteosarcoma.Target: OthersMifamurtide is an immunomodulator with antitumor effects that appear to be mediated via activation of monocytes and macrophages. Mifamurtide is generally well tolerated; adverse events attributed to administration of the drug include chills, fever, headache, nausea, and myalgias.

Product Name Cilengitide

CAS 188968-51-6

hypothetica formula C27H40N8O7

hypothetica pondus 588.66

density 1.41±0.1 g/cm3(Predicta)

solubility ≥29.43 mg/mL in DMSO;≥22.56 mg/mL in H2O

Acidum coefficiens (pKa) 4.01±0.10 (Predicta)

Cilengitide is an important neurotransmitter and peptide drug with extensive pharmacological effects and application prospects. As an integrin inhibitor, silengeptide mainly regulates cellular signaling processes by binding to integrin receptors, thereby exerting various pharmacological effects.

1. Integrin inhibitory effect

2. Antitumor effect

3. The impact on angiogenesis

4. Immunomodulatory effect

5. Other pharmacological effects

Product type: Peptides

Product reference: PTX-OS-214766-78-6-47

CAS: 214766-78-6

Product name: Degarelix PeptideNumber 782500-75-8

 form/format: White powder

Molecular formula: C82H103ClN18O16

Molecular weight: 1632.28

Degarelix, is a competitive and reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist.

Name Albiglutide

Chemical Name ((8-glycine)human glucagon-like peptide 1-(7-36)-peptidyl)((8-glycine)human glucagon-like peptide 1-(7-36)-peptidyl)(human serum albumin (585 residues));

Synonyms Albugon; Eperzan; Tanzeum™; Naliglutide; GSK716155; HSDB 8282; UNII-5E7U48495E;

Molecular Formula C3232H5032N864O979S41

Molecular Weight 72970.00000

CAS Number 782500-75-8

Albiglutide Fragment is a fragment of the soybean trypsin inhibitor, which is a protein that has been found to inhibit the activity of pancreatic enzymes. The fragment was designed to be used in diagnosis and treatment of infectious diseases. Albiglutide Fragment binds to the glucagon-like peptide (GLP) receptors on cells in the intestine and pancreas, inhibiting the production of pro-inflammatory cytokines and reducing inflammation. When it is bound to GLP receptors, albiglutide fragment blocks cell signals that lead to diabetes, obesity, and metabolic syndrome. Albiglutide Fragment can also be used as a contrast agent for imaging techniques such as magnetic resonance imaging or ultrasound. It binds to cells in high concentrations and can help visualize profiles of these cells.

Name Teduglutide

Synonyms Gattex; Glucagon-like peptide II [2-glycine] (human); ALX 0600

Molecular Formula C164H252N44O55S

Molecular Weight 3752.13

CAS 197922-42-2

EC Number 812-261-5

Teduglutide is a dipeptidyl peptidase IV resistant glucagon-like peptide 2 (GLP-2) analogue. Teduglutide is associated with trophic effects on gut mucosa. Teduglutide can be used for the research of short bowel syndrome (SBS) and Crohn's disease.